Kazia Therapeutics Limited carries a market capitalization of 18.91M, placing it among publicly traded companies globally.
| Market Cap | 18.91M |
| Enterprise Value | N/A |
Kazia Therapeutics Limited's stock has declined approximately -8.57143% over the past 52 weeks. The 50-day moving average sits at 0.12, while the 200-day moving average is 0.15.
| Beta (5Y) | N/A |
| 52-Week Price Change | -8.57143% |
| 50-Day Moving Average | 0.12 |
| 200-Day Moving Average | 0.15 |
| Average Volume (20 Days) | N/A |
Kazia Therapeutics Limited's most recent stock split took place on November 17, 2017 with a 10:1 split ratio.
| Last Split Date | 11/17/2017 |
| Split Ratio | 10:1 |